Sigma Planning Corp’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Sigma Planning Corp’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,432	Closed	-$247K	–	1092
2019 Q2	$247K	Buy	1,432 +8	+0.6%	+$1.38K	0.01%	821
2019 Q1	$240K	Buy	+1,424	New	+$212K	0.01%	774
2018 Q4	–	Sell	-2,169	Closed	-$375K	–	1007
2018 Q3	$375K	Buy	2,169 +436	+25%	+$62.9K	0.02%	592
2018 Q2	$242K	Buy	+1,733	New	+$246K	0.02%	743
2018 Q1	–	Sell	-1,886	Closed	-$249K	–	936
2017 Q4	$249K	Buy	+1,886	New	+$222K	0.02%	684
2016 Q1	–	Sell	-12,122	Closed	-$842K	–	786
2015 Q4	$842K	Sell	12,122 -392	-3%	-$31.9K	0.12%	205
2015 Q3	$1.14M	Sell	12,514 -488	-4%	-$54.3K	0.18%	137
2015 Q2	$1.6M	Sell	13,002 -125	-1%	-$14.2K	0.22%	112
2015 Q1	$1.2M	Sell	13,127 -4,318	-25%	-$351K	0.16%	159
2014 Q4	$1.18M	Buy	+17,445	New	+$1.27M	0.16%	155

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sigma Planning Corp's GWPH Position: Q3 2019 in Review

Sigma Planning Corp sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2019, closing a stake of 1,432 shares — an estimated $247K sold.

Sigma Planning Corp first reported a position in GWPH in Q4 2014 and held it in 10 quarters. The position peaked at $1.6M in Q2 2015. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

Sigma Planning Corp reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
Sigma Planning Corp sold 1,432 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $247K.
Sigma Planning Corp first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and held it in 10 quarters.
Sigma Planning Corp's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.6M in Q2 2015.
316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Sigma Planning Corp's 13F filing for Q3 2019, filed 1 Nov 2019.